How Ensartinib Works in ALK-Positive Non-Small Cell Lung Cancer: Mechanism Explained │ PHARMACOLOGY
3:43
How Ensartinib Works in ALK-Positive Non-Small Cell Lung Can…
473 viewsJan 2, 2025
YouTubePharmacology Insights
Dr. Horn on Monitoring Response and Resistance to Ensartinib in ALK+ NSCLC
Dr. Horn on Monitoring Response and Resistance to Ensartinib in A…
340 viewsApr 11, 2019
YouTubeOncLive
4 ALK-Targeted Cancer Drugs in 2025 #dengyuemed #cancertreatment
0:15
4 ALK-Targeted Cancer Drugs in 2025 #dengyuemed #cancertreatm…
167 views10 months ago
YouTubeDengYue Sheldon
GRACE Targeted Therapies Lung Cancer 2021 - Data Learned from Ensartinib for ROS1 in Clinical Trial?
2:01
GRACE Targeted Therapies Lung Cancer 2021 - Data Learned from …
42 viewsMar 12, 2022
YouTubeGlobal Resource for Advancing Cancer Education
Emerging treatment strategies in EGFR-mutant NSCLC: osimertinib combinations and beyond
1:31
Emerging treatment strategies in EGFR-mutant NSCLC: osimertinib …
113 viewsOct 8, 2024
YouTubeVJOncology
Challenges in first line ALK positive NSCLC management and emerging data on ALK TKIs in ALK posi...
13:06
Challenges in first line ALK positive NSCLC management and emergin…
147 viewsSep 30, 2021
YouTubeecancer
Treating With Osimertinib in EGFR-Mutated NSCLC
4:04
Treating With Osimertinib in EGFR-Mutated NSCLC
479 viewsJun 4, 2019
YouTubeOncLive
0:15
用于非小细胞肺癌！恩沙替尼获FDA批准上市
196 viewsDec 19, 2024
bilibili北京医伴旅
ALK阳性晚期肺癌患者的福音：国产恩莎替尼成功上市,恩沙替尼- 抖音
May 30, 2021
douyin.com
0:23
首款国产肺癌ALK抑制剂恩沙替尼上市！
328 viewsDec 16, 2020
bilibili中国蓝新闻
0:08
Топ-3 препарата против #ракалёгких, меняющих лечени…
462 views1 month ago
YouTubeDengYuePharma
5:37
How to Choose the Best First-Line Therapy for Patients With EGFR-M…
829 views10 months ago
YouTubeOncUpdates: Latest Oncology Insights
15:24
eXalt 3：恩沙替尼.一线临床研究完整-雷颖
735 viewsApr 26, 2021
bilibili乐城阿七
0:06
💡Discover Some ALK, ROS1 Targeted Drugs in 2025
197 views10 months ago
YouTubeDengYue Sheldon
4:18
Elacestrant in ER+/HER2- mBC: Overview of the EMERALD subgro…
6.3K viewsDec 3, 2024
YouTubeCOR2ED The Heart of Medical Education
The EMERALD Trial: Elacestrant Mechanism of Action, Study Desig…
Nov 9, 2022
targetedonc.com
19:06
【狙击耐药前列腺癌】二代AR拮抗剂_恩杂鲁胺的药物设计思路和合成 …
1.1K viewsMar 25, 2025
bilibili890转有机
10:04
抗体偶联药物之十二：多癌种抗癌神药Enhertu
2.3K viewsFeb 13, 2022
bilibili泉禺
Ongoing Study of Elacestrant   Targeted Therapy: ELEVATE | Tar…
10 months ago
targetedonc.com
Balancing Treatment Intensity and Resistance Mechanisms in First-Li…
Feb 27, 2025
targetedonc.com
8:53
Elacestrant in ER+/HER2- mBC with ESR1-mut tumors: Overview of th…
3K viewsApr 22, 2025
YouTubeCOR2ED The Heart of Medical Education
1:24
Phase I Results for Enasidenib in AML
306 viewsJun 7, 2017
YouTubeTargeted Oncology
EMERALD subgroup analysis: Elacestrant in endocrine-sensitiv…
Nov 25, 2024
targetedonc.com
ADELA Study - Elacestrant Everolimus vs. Elacestrant in ER /…
301 views11 months ago
vumedi.com
6:34
Targeted Therapies in EGFR-Mutated NSCLC: Managing Treatm…
447 views10 months ago
YouTubeOncology Brothers Clips
Sequencing Endocrine and Targeted Therapies After CDK4/6 Inhibitor i…
2 months ago
onclive.com
The Impact of Clinical and Genomic Factors on Real-World Outcomes …
3 months ago
onclive.com
10:01
Injection Training | ENSPRYNG® (satralizumab)
Dec 14, 2022
enspryng.com
3:32
ENHERTU: Breakthrough Hope for HER2 Positive Cancers
50.2K viewsSep 2, 2023
YouTubePharma News & Analysis
4:32
恩沙替尼eXalt 3 研究最新数据重磅公布
Jan 28, 2021
qq.com
See more videos
Static thumbnail place holder